🇺🇸 Venlafaxine XR in United States

623 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 83 reports (13.32%)
  2. Depression — 70 reports (11.24%)
  3. Nausea — 67 reports (10.75%)
  4. Dizziness — 66 reports (10.59%)
  5. Fatigue — 64 reports (10.27%)
  6. Anxiety — 63 reports (10.11%)
  7. Dyspnoea — 55 reports (8.83%)
  8. Fall — 52 reports (8.35%)
  9. Off Label Use — 52 reports (8.35%)
  10. Insomnia — 51 reports (8.19%)

Source database →

Other Psychiatry / Mental Health approved in United States

Frequently asked questions

Is Venlafaxine XR approved in United States?

Venlafaxine XR does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Venlafaxine XR in United States?

Ministry of Health & Welfare, Korea is the originator. The local marketing authorisation holder may differ — check the official source linked above.